Correlation Between HP and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HP and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HP and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HP Inc and Cannara Biotech, you can compare the effects of market volatilities on HP and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HP with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of HP and Cannara Biotech.

Diversification Opportunities for HP and Cannara Biotech

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between HP and Cannara is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding HP Inc and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and HP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HP Inc are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of HP i.e., HP and Cannara Biotech go up and down completely randomly.

Pair Corralation between HP and Cannara Biotech

Considering the 90-day investment horizon HP Inc is expected to generate 0.35 times more return on investment than Cannara Biotech. However, HP Inc is 2.9 times less risky than Cannara Biotech. It trades about 0.05 of its potential returns per unit of risk. Cannara Biotech is currently generating about -0.01 per unit of risk. If you would invest  3,310  in HP Inc on September 12, 2024 and sell it today you would earn a total of  184.00  from holding HP Inc or generate 5.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HP Inc  vs.  Cannara Biotech

 Performance 
       Timeline  
HP Inc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HP Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, HP may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

HP and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HP and Cannara Biotech

The main advantage of trading using opposite HP and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HP position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind HP Inc and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios